Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults

Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis

(2022) Shi-Yuan Wang et al.   Human Vaccines & Immunotherapeutics

Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters

(2022) Marie-Clotilde Bernard et al.   Scientific Reports

Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

(2022) Agam K. Rao et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Safety and immunogenicity of a serum-free purified Vero rabies vaccine in healthy adults: A randomised phase II pre-exposure prophylaxis study

(2022) Sylvie Pichon et al.   VACCINE

Serum-free purified Vero rabies vaccine is safe and immunogenic in children: Results of a randomized phase II pre-exposure prophylaxis regimen study

(2022) Beatriz Quiambao et al.   VACCINE

Safety and efficacy of rabies immunoglobulin in pediatric patients with suspected exposure

(2021) Nicholas Hobart-Porter et al.   Human Vaccines & Immunotherapeutics

Detection and quantification of anti-rabies glycoprotein antibodies: current state and perspectives

(2021) Maria Celeste Rodriguez et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

The Route of Administration of Rabies Vaccines: Comparing the Data

(2021) Deborah J. Briggs et al.   Viruses-Basel

Challenges of Rabies Serology: Defining Context of Interpretation

(2021) Susan M. Moore   Viruses-Basel

Advanced maternal age pregnancy and its adverse obstetrical and perinatal outcomes in Ayder comprehensive specialized hospital, Northern Ethiopia, 2017: a comparative cross-sectional study

(2020) Mihret-ab Mehari et al.   BMC Pregnancy and Childbirth

Preparation and qualification of internal rabies reference standards for use in the rabies rapid fluorescent focus inhibition test

(2020) Tatyana M. Timiryasova et al.   Scientific Reports

Rapid fluorescent focus inhibition test optimization and validation: Improved detection of neutralizing antibodies to rabies virus

(2019) Tatyana M. Timiryasova et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial

(2019) Mark A. Matson et al.   Human Vaccines & Immunotherapeutics

Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis

(2018) Scott Preiss et al.   Expert Review of Vaccines

Novel vaccines: Technology and development

(2018) Sarita U. Patil et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Rabies vaccines: WHO position paper, April 2018 – Recommendations

(2018) World Health Organization   VACCINE

Replacement of in vivo human rabies vaccine potency testing by in vitro glycoprotein quantification using ELISA – Results of an international collaborative study

(2017) Sylvie Morgeaux et al.   VACCINE

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study

(2017) Gadey Sampath et al.   Human Vaccines & Immunotherapeutics

Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen)

(2015) BJ Mahendra et al.   Human Vaccines & Immunotherapeutics

Correction: Estimating the Global Burden of Endemic Canine Rabies

(2015) Katie Hampson et al.   PLoS Neglected Tropical Diseases

Estimating the Global Burden of Endemic Canine Rabies

(2015) Katie Hampson et al.   PLoS Neglected Tropical Diseases

The Cost of Canine Rabies on Four Continents

(2013) A. Anderson et al.   Transboundary and Emerging Diseases

A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China

(2013) Rongcheng Li et al.   VACCINE

A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab™ for pre-exposure use in healthy adults: Results from a randomized controlled phase-II trial

(2013) Sylvie Pichon et al.   VACCINE

Rabies Postexposure Prophylaxis in Routine Practice in View of the New Centers for Disease Control and Prevention and World Health Organization Recommendations

(2012) M. Uwanyiligira et al.   CLINICAL INFECTIOUS DISEASES

Rabies Exposures, Post-Exposure Prophylaxis and Deaths in a Region of Endemic Canine Rabies

(2008) Katie Hampson et al.   PLoS Neglected Tropical Diseases